Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia.
about
Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compoundsLipoproteins and lipoprotein metabolism in periodontal disease.Consensus statement on management of dyslipidemia in Indian subjects.A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial.Fenofibrate and metabolic syndrome.Pharmacotherapy of dyslipidemias in the adult population.Lipid-lowering effects of ezetimibe and simvastatin in combination.Does it make sense to combine statins with other lipid-altering agents following AIM-HIGH, SHARP and ACCORD?Lipid-lowering drug therapies and chronic obstructive pulmonary disease: lung failure or just heart failure?Effect of bezafibrate on monocyte cytokine release and systemic inflammation in patients with impaired fasting glucose.
P2860
Q30408018-BAA7948E-162F-46DA-A62B-E35FDDC80101Q34106350-3D70A393-AFBC-439F-94EF-AED27464E2B7Q34980772-06BE5C3F-C5EA-4C07-A951-CB2077A9B6E1Q36117465-FE7C5A69-88D3-4C4D-A5B9-17E88DA05EA5Q37612824-F3C21AD2-ADB7-4403-A390-9EAB9152641FQ37801374-3C48BD23-9119-4A66-A060-68EDB9B373E6Q37859778-A96969F6-B841-4C16-BD20-6360D24ADA14Q38067634-16802236-F9C3-41CA-9A6E-62FD3BF73BE2Q38181583-17D43978-0F60-48E5-BEBF-A1BC70973C81Q51385582-2CB99F0D-78E6-478A-B998-A91DA7E7FA81
P2860
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia.
@en
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia.
@nl
type
label
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia.
@en
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia.
@nl
prefLabel
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia.
@en
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia.
@nl
P921
P1476
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia.
@en
P304
P356
10.1097/HCO.0B013E32832C0B3D
P577
2009-07-01T00:00:00Z